Paykel-backed NZ serum exporter snaps up Aussie rival

Paykel-backed NZ serum exporter snaps up Aussie rival
Acquiring CellSera adds a 'critical new serum' to the Auckland firm’s existing product range. (Photo: supplied)
Dan Brunskill
Animal serum and plasma exporter Auckland BioSciences (ABS) has purchased an Australian competitor as it seeks to become a global industry leader.The company manufactures and exports premium New Zealand-made animal-derived serum and plasma, which are key ingredients for growing cells for bio-pharmaceutical manufacturing and medical research. While it’s not a glamourous export, this serum is vital to biotech research and the production of vaccines – including some for covid-19.“While our business is operationally complex,...

More Markets

NZ sharemarket up 0.5% ahead of long weekend
Markets Market Close

NZ sharemarket up 0.5% ahead of long weekend

Pacific Edge's share price fell 7.32%.

Tom Raynel 24 Apr 2025
Pacific Edge suffers another setback in US
Markets

Pacific Edge suffers another setback in US

Shares in cancer diagnostics company Pacific Edge are down 2.44% to $0.120 after another setback in the US market.The US District Court for the Middle District of Pennsylvania has determined that it does not have jurisdiction to review a Local Coverage Determination (LCD) that co...

Staff reporters 24 Apr 2025
Listed retailers stand to gain from Trump tariffs:  Forsyth Barr
Retail

Listed retailers stand to gain from Trump tariffs: Forsyth Barr

Forsyth Barr lifted its KMD Brands target price by 10.4% after Trump tariff walkbacks.

Gregor Thompson 24 Apr 2025
NZ sharemarket rises as Trump backs down
Markets Market Close

NZ sharemarket rises as Trump backs down

The S&P/NZX 50 Index closed up 1.01% or 119.78 points.

Tom Raynel 23 Apr 2025